Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lexaria Bioscience Corp.LEXX · Entity 7641 | Director · President & CSO | July 29, 2025 | July 30, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lexaria Bioscience Corp.
Report date July 29, 2025 · Filed July 30, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| common sharesSEC Table I · non-derivative | Direct | 5,376 |
Reported balance
After 2025-07-29 transaction · row 2
1 source rowRow 2 · 2025-07-29 · Purchase · Acquired 5,376 · Balance 5,376 |
| common sharesSEC Table I · non-derivative | IndirectPrivate Holding Company | 54,075 |
Reported balance
Holding disclosure · report date 2025-07-29 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 54,075 |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $3.00 · Expires 2026-04-26 | Direct | 18,000 |
Reported balance
Holding disclosure · report date 2025-07-29 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 18,000 |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $3.00 · Expires 2026-06-08 | Direct | 36,334 |
Reported balance
Holding disclosure · report date 2025-07-29 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 36,334 |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $3.00 · Expires 2026-09-01 | Direct | 51,334 |
Reported balance
Holding disclosure · report date 2025-07-29 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 51,334 |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $2.91 · Expires 2027-08-29 | Direct | 81,334 |
Reported balance
Holding disclosure · report date 2025-07-29 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 81,334 |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $1.15 · Expires 2028-10-26 | Direct | 111,334 |
Reported balance
Holding disclosure · report date 2025-07-29 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 111,334 |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $2.36 · Expires 2029-04-26 | Direct | 160,834 |
Reported balance
Holding disclosure · report date 2025-07-29 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 160,834 |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $1.04 · Expires 2030-05-15 | Direct | 310,834 |
Reported balance
Holding disclosure · report date 2025-07-29 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 310,834 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 29, 2025 Filed Jul 30, 2025 11:34 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | Purchasecommon shares | 5,376 | $0.93 | $4,988.93 |
DisclosureSEC source: 0001348362-25-000014 · primary_doc.xml · nonDerivative · entry 2 DOCHERTY JOHN MARTIN · CIK 0001638727 · Director · President & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,376 Read SEC document |
| May 15, 2025 Filed May 16, 2025 17:19 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | GrantStock Options · Derivative | 150,000 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001348362-25-000008 · primary_doc.xml · derivative · entry 8 DOCHERTY JOHN MARTIN · CIK 0001638727 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310,834 Underlying: Common Shares · 150,000 shares Expires 2030-05-15 Read SEC document |
| April 26, 2024 Filed May 10, 2024 16:34 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | GrantStock Options · Derivative | 49,500 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001855763-24-000004 · primary_doc.xml · derivative · entry 8 DOCHERTY JOHN MARTIN · CIK 0001638727 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,168 Underlying: Common Shares · 49,500 shares Expires 2029-04-26 Read SEC document |
| October 26, 2023 Filed Oct 30, 2023 12:47 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | GrantStock Options · Derivative | 30,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001855763-23-000008 · primary_doc.xml · derivative · entry 7 DOCHERTY JOHN MARTIN · CIK 0001638727 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,668 Underlying: Common Shares · 30,000 shares Expires 2028-10-26 Read SEC document |
| August 29, 2022 Filed Aug 29, 2022 17:26 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | GrantStock Options · Derivative | 30,000 | $0.00 Strike: $2.91 | $0.00 |
DisclosureSEC source: 0001855763-22-000009 · primary_doc.xml · derivative · entry 6 DOCHERTY JOHN MARTIN · CIK 0001638727 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,668 Underlying: Common Shares · 30,000 shares Expires 2027-08-29 Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 13:49 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | GrantStock Options · Derivative | 15,000 | $0.00 Strike: $6.23 | $0.00 |
DisclosureSEC source: 0001855763-21-000026 · primary_doc.xml · derivative · entry 5 DOCHERTY JOHN MARTIN · CIK 0001638727 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,668 Underlying: Common Shares · 15,000 shares Expires 2026-09-01 Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 13:40 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | GrantStock Options · Derivative | 18,334 | $0.00 Strike: $7.08 | $0.00 |
DisclosureSEC source: 0001855763-21-000020 · primary_doc.xml · derivative · entry 4 DOCHERTY JOHN MARTIN · CIK 0001638727 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,668 Underlying: Common Shares · 18,334 shares Expires 2026-06-08 Read SEC document |
| May 07, 2021 Filed Jun 9, 2021 13:34 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | OtherStock Options · Derivative | 18,334 | $0.00 Strike: $14.10 | $0.00 |
DisclosureSEC source: 0001855763-21-000019 · primary_doc.xml · derivative · entry 5 DOCHERTY JOHN MARTIN · CIK 0001638727 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,334 Underlying: Common Shares · 18,334 shares Expires 2025-02-07 F1 · kind: Cancellation of Options Read SEC document |
| April 26, 2021 Filed Apr 27, 2021 16:58 UTC | Lexaria Bioscience Corp. LEXX · Entity 7641 | GrantStock Options · Derivative | 18,000 | $0.00 Strike: $5.31 | $0.00 |
DisclosureSEC source: 0001855763-21-000005 · primary_doc.xml · derivative · entry 4 DOCHERTY JOHN MARTIN · CIK 0001638727 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,668 Underlying: Common Shares · 18,000 shares Expires 2026-04-26 Read SEC document |
| April 23, 2020 Filed Apr 23, 2020 13:40 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Grantstock options · Derivative | 400,000 | $0.00 Strike: $0.32 | $0.00 |
DisclosureSEC source: 0001638727-20-000002 · primary_doc.xml · derivative · entry 4 DOCHERTY JOHN MARTIN · CIK 0001638727 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250,000 Underlying: common shares · 400,000 shares Expires 2025-04-23 Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 12:56 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | Otherstock options · Derivative | 400,000 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001348362-20-000001 · primary_doc.xml · derivative · entry 5 DOCHERTY JOHN MARTIN · CIK 0001638727 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 850,000 Underlying: common shares · 400,000 shares Expires 2023-05-31 F1 · kind: Cancellation of Options Read SEC document |
| February 07, 2020 Filed Feb 12, 2020 13:13 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | GrantStock Options · Derivative | 550,000 | $0.00 Strike: $0.47 | $0.00 |
DisclosureSEC source: 0001638727-20-000001 · primary_doc.xml · derivative · entry 4 DOCHERTY JOHN MARTIN · CIK 0001638727 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250,000 Underlying: Common Shares · 550,000 shares Expires 2025-02-07 Read SEC document |
| December 30, 2019 Filed Dec 30, 2019 17:26 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | OtherStock Options · Derivative | 550,000 | $0.09 Strike: $0.09 | $49,500.00 |
DisclosureSEC source: 0001348362-19-000008 · primary_doc.xml · derivative · entry 5 DOCHERTY JOHN MARTIN · CIK 0001638727 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700,000 Underlying: Common Shares · 550,000 shares Expires 2020-03-26 F1 · kind: Cancellation of Options Read SEC document |
| August 31, 2018 Filed Sep 4, 2018 16:16 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | GrantCommon Shares | 36,500 | $2.07 | $75,555.00 |
DisclosureSEC source: 0001638727-18-000003 · primary_doc.xml · nonDerivative · entry 2 DOCHERTY JOHN MARTIN · CIK 0001638727 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · Private holding company Disclosed balance after: 1,622,250 Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 15:05 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | GrantCommon Shares | 91,250 | $1.24 | $113,150.00 |
DisclosureSEC source: 0001638727-18-000002 · primary_doc.xml · nonDerivative · entry 3 DOCHERTY JOHN MARTIN · CIK 0001638727 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Private holding company Disclosed balance after: 1,585,750 Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 15:05 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | GrantCommon Shares | 182,500 | $1.32 | $240,900.00 |
DisclosureSEC source: 0001638727-18-000002 · primary_doc.xml · nonDerivative · entry 2 DOCHERTY JOHN MARTIN · CIK 0001638727 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Private holding company Disclosed balance after: 1,494,500 Read SEC document |
| May 31, 2018 Filed May 31, 2018 14:25 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | GrantStock Options · Derivative | 400,000 | $1.53 Strike: $1.53 | $612,000.00 |
DisclosureSEC source: 0001638727-18-000001 · primary_doc.xml · derivative · entry 4 DOCHERTY JOHN MARTIN · CIK 0001638727 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250,000 Underlying: Common Shares · 400,000 shares Expires 2023-05-31 Read SEC document |
| December 01, 2017 Filed Dec 1, 2017 16:21 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | GrantCommon Shares | 35,000 | $0.82 | $28,700.00 |
DisclosureSEC source: 0001103780-17-000003 · primary_doc.xml · nonDerivative · entry 2 DOCHERTY JOHN MARTIN · CIK 0001638727 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Private holding company Disclosed balance after: 1,312,000 Read SEC document |
| June 22, 2017 Filed Jun 22, 2017 19:22 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | GrantCommon Shares | 210,000 | $0.30 | $61,950.00 |
DisclosureSEC source: 0001638727-17-000002 · primary_doc.xml · nonDerivative · entry 2 DOCHERTY JOHN MARTIN · CIK 0001638727 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · Private holding company Disclosed balance after: 1,277,000 Read SEC document |
| May 15, 2017 Filed May 18, 2017 20:37 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | OtherWarrants · Derivative | 143,000 | $0.23 Strike: $0.23 | $32,890.00 |
DisclosureSEC source: 0001638727-17-000001 · primary_doc.xml · derivative · entry 5 DOCHERTY JOHN MARTIN · CIK 0001638727 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · Private holding company Disclosed balance after: 0 Underlying: Common Shares · 143,000 shares Expires 2017-05-15 F1 · kind: Warrants expired unexercised. Read SEC document |
| October 11, 2016 Filed Oct 11, 2016 17:11 UTC | Lexaria Bioscience Corp. LXRP · Entity 7641 | GrantCommon Shares | 252,000 | $0.14 | $35,280.00 |
DisclosureSEC source: 0001638727-16-000007 · primary_doc.xml · nonDerivative · entry 2 DOCHERTY JOHN MARTIN · CIK 0001638727 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · Private holding company Disclosed balance after: 1,067,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.